Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze

Pharmacology, Biochemistry and Behavior

Volumn 52, Issue 4, 1995, Pages 805-813

  Rodgers, R J ^a   Cole, J C ^a   Aboualfa, K ^a   Stephenson, L H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anxiogenic; Elevated plus maze; Ethological analysis; FG 7142; Isoproterenol Mice; Pentylenetetrazol; Sodium lactate

Indexed keywords

ANXIOGENIC AGENT; ISOPRENALINE; LACTIC ACID; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ETHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PANIC; PRIORITY JOURNAL; SEIZURE; TRANQUILIZING ACTIVITY;

ANIMAL; ANXIETY; APPETITE DEPRESSANTS; BEHAVIOR, ANIMAL; CARBOLINES; DOSE-RESPONSE RELATIONSHIP, DRUG; LACTATES; MALE; MAZE LEARNING; MICE; MICE, INBRED DBA; PENTYLENETETRAZOLE; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; MURINAE;

EID: 0028824980     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)00190-8     Document Type: Article

References (64)

1. Does the pentylenetetrazol (PTZ) cue reflect PTZ-induced kindling or PTZ-induced anxiogenesis?
2. The provocation of anxiety states in humans and its possible significance for the pathogenesis of these disorders
3. The benzodiazepine receptor inverse agonists β-CCM and Ro15-3505 both reverse the anxiolytic effects of ethanol in mice
4. 1B characterizing agents in the mouse elevated plus-maze
5. Ultrasonic vocalizations are elicited from rat pups in the home cage by pentylenetetrazol and U50,488, but not naltrexone
6. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze
7. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: Comparison with haloperidol
8. Proconflict effect of GABA receptor complex antagonists
9. β-Carbolines enhance shock-induced suppression of drinking in rats
10. Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse
11. Ethopharmacological analysis of rat behavior on the elevated plus-maze
12. Comparative effects of valproate, anxiolytic, or anxiogenic drugs on the light/dark aversion test
13. Heterogeneity of CCK-B receptors involved in animal models of anxiety
14. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs
15. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors
16. Behavioural detection of anxiolytic action
17. Proconvulsant action of CGS8216
18. Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat
19. The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro15-1788 but not by CGS8216
20. Pentylenetetrazol can induce a conditioned place preference
21. Cross-generalization between an ecologically relevant stimulus and a pentylenetetrazol-discriminative cue
22. Panic disorder: Fact or fiction?
23. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro15-1788
24. Animal models of anxiety
25. β-Carboline and pentylenetetrazol effects on conflict behavior in the rat
26. Can animal tests of anxiety detect panic-promoting agents?
27. Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites
28. Social competition in dominant rats can be attenuated by anxiogenic drugs
29. Stretched attend posture, a nonsocial form of ambivalence, is sensitive to a conflict-reducing drug action
30. Acoustic startle induced ultrasonic vocalization in the rat: A novel animal model of anxiety?
31. Anxiolytic effect of indole-3-pyruvic acid (IPA)in mice
32. The use of a plus-maze to measure anxiety in the mouse
33. Interactions of three benzodiazepine receptor inverse agonists with ethanol in the plus-maze test of anxiety
34. Ethologically based animal models of anxiety disorders
35. On the effects of lindane on the plus-maze model of anxiety
36. Effect of putative anxiolytics and anxiogenics on a modified X-maze apparatus
37. Interaction of pregnanolone and pregnenolone sulfate with ethanol and pentobarbital
38. The effects of compounds acting at the benzodiazepine receptor complex on the ultrasonic calling of mouse pups.
39. The pharmacology of human anxiety
40. FG 7142 selectively decreases nonpunished responding, but has no anxiogenic effects on time allocation in a conflict schedule
41. Multiple sites of action for anxiogenic drugs: Behavioural, electrophysiological and biochemical correlations
42. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
43. 3-(Methoxycarbonyl)amino-β-carboline, a selective antagonist of the sedative effects of benzodiazepines
44. Anxiety enhancement in the murine elevated plus-maze by immediate prior exposure to social Stressors
45. The elevated plus-maze: Pharmacology, methodology and ethology
46. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety
47. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: Profile comparisons with 8-OH-DPAT, CGS120066B, TFMPP and mCPP
48. 2 receptor ligands modulate the behaviour of mice in the elevated plus-maze
49. Benzodiazepine ligands, nociception and ‘defeat’ analgesia in mice
50. Metrazol tolerance in a ‘normal’ volunteer population
51. The benzodiazepine antagonist CGS 8216 decreases both shocked and unshocked drinking in rats
52. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions
53. Effects of a single or repeated administration of the benzodiazepine inverse agonist FG 7142 on behaviour and cortical adrenoceptor binding in the rat
54. Proconflict and electrocorticographic effects of drugs modulating GABAergic neurotransmission
55. 2 antagonists endowed with anxiolytic properties in rodents?
56. Anxiogenic properties of beta-CCE and FG 7142: A review of promises and pitfalls
57. Ro15-I788, CGS 8216, picrotoxin, and pentylenetetrazol: Do they antagonize anxiolytic drug effects through an anxiogenic action?
58. 1A agonists: Animal models
59. Anxiogenic stimuli in the elevated plus-maze
60. Selective effect on punished responding vs. unpunished responding in a conflict test as the criterion for anxiogenic activity
61. Effects of convulsant ligands of the GABA-benzodiazepine receptor complex in conflict and learning tasks in mice
62. Effects of DN-2337, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze